Morito Endo
Hachinohe, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Recurrent C3 glomerulopathy after prolonged remission.
Journal: Pediatric nephrology (Berlin, Germany)
Published: February 24, 2026
Unveiling long-standing low-molecular-weight proteinuria: A proximal tubular mitochondrial enzyme impairment caused by EHHADH mutation.
Journal: Pediatric nephrology (Berlin, Germany)
Published: August 27, 2025
Toll-Like Receptor 3 Activation in Lupus Nephritis: A Renal Signature Supporting "Pseudoviral" Immunity.
Journal: International journal of rheumatic diseases
Published: July 03, 2025
Contrasting Role of COMMD5 in Renal Cell Carcinoma: Tumor Suppression and Metastatic Enhancement.
Journal: Anticancer research
Published: February 21, 2025
COMMD5 counteracts cisplatin-induced nephrotoxicity by maintaining tubular epithelial integrity and autophagy flux.
Journal: American journal of physiology. Renal physiology
Published: September 19, 2024
Long-term outcome of tacrolimus-based immunosuppressive treatment for patients with paediatric-onset lupus nephritis.
Journal: Nephrology (Carlton, Vic.)
Published: August 21, 2024
Abnormal epigenetic memory of mesenchymal stem and progenitor cells caused by fetal malnutrition induces hypertension and renal injury in adulthood.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: March 09, 2024
Science electives in high school will improve nutrition knowledge but not enough to make accurate decisions.
Journal: Nutrition research and practice
Published: May 28, 2022
Implantation of dedifferentiated fat cells ameliorated antineutrophil cytoplasmic antibody glomerulonephritis by immunosuppression and increases in tumor necrosis factor-stimulated gene-6.
Journal: Stem cell research & therapy
Published: September 29, 2021
COMMD5 Inhibits Malignant Behavior of Renal Cancer Cells.
Journal: Anticancer research
Published: April 22, 2021
Transcriptional Suppression of Diabetic Nephropathy with Novel Gene Silencer Pyrrole-Imidazole Polyamides Preventing USF1 Binding to the TGF-β1 Promoter.
Journal: International journal of molecular sciences
Published: December 11, 2020
Contribution of TGF-β1 and Effects of Gene Silencer Pyrrole-Imidazole Polyamides Targeting TGF-β1 in Diabetic Nephropathy.
Journal: Molecules (Basel, Switzerland)
Published: January 08, 2020
Last Updated: 09/26/2026